The expansion of CD169 + macrophages correlates with B-cell expansion in these lymph nodes, and B-cell depletion negates the anti-metastatic effects of CD169 + macrophage deficiency, highlighting a protective role for CD169 + lymph node macrophages in breast cancer metastasis [166]. Here, SIGLEC1 is linked to breast carcinoma.